IOBT
IOBT
NASDAQ · Biotechnology

Io Biotech Inc

$0.35
+0.03 (+9.27%)
As of Feb 8, 2:23 PM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 7 58%
Hold 5 42%
Sell 0 0%
Price Target
Analyst Price Target +10,408.6% upside
Low Target $22.85
Average Target $36.78
High Target $42.48
Current Price $0.35
Current
$0.35
Target
$36.78
$22.85 $36.78 avg $42.48
Scenario Analysis
Bear Case
$22.85
6,428.6%
Low target
Base Case
$36.78
+10,408.6%
Avg target
Bull Case
$42.48
+12,037.1%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$47.16
-99.3% from high
52-Week Low
$17.34
+-98.0% from low
Target vs 52W High
$36.78
-22.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%